Reducing Cutibacterium Acnes in Shoulder Surgery
Official title: Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients
Run by Nantes University Hospital · NCT04028401 · Data updated 2026-11-12
This study is testing if using a benzoyl peroxide cream on the skin for five days before shoulder surgery can help reduce a bacteria that may cause infections in men having shoulder operations.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 110 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 6 sites (Angers and 5 other locations) |
| Status | Recruiting |
| Started | June 19, 2020 |
| Main results expected | June 2029 |
| Study ends | June 2029 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT04028401 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adult male patients scheduled for shoulder arthroplasty without prior surgeries on the same shoulder.
✕Probably not a fit
Patients with a history of shoulder surgery, acute trauma, or certain medical conditions such as cancer or immunosuppression may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of applying a 5% benzoyl peroxide topical treatment on the skin before shoulder surgery to reduce the presence of Cutibacterium acnes, a bacterium linked to post-operative infections. The study focuses on male patients undergoing various types of shoulder arthroplasty for conditions like osteoarthritis or rotator cuff tears. By applying the treatment for five days prior to surgery, the researchers hope to decrease the bacterial load in the surgical area, potentially improving surgical outcomes. The trial is interventional and is currently in Phase 3.
Why it matters
Potential benefit: If successful, this approach could significantly lower the risk of post-operative infections in male patients undergoing shoulder surgery.
How similar studies have gone: While the specific application of benzoyl peroxide in this context may be novel, similar studies have shown that optimizing skin preparation can reduce infection rates in surgical settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients, Adult patients, * Patient without a history of surgical intervention on the operated shoulder, * Patient managed for glenohumeral, partial (cup or anatomical hemi- arthroplasty) or total (anatomical or inverted) glenohumeral arthroplasty placement for primary osteoarthritis, or secondary to necrosis, massive rotator cuff tear or old fracture. * Patients affiliated to a social security system * Patients who have given their informed and written consent Exclusion Criteria: * Patient with arthroplasty for resumption of previous shoulder surgery or failure of arthroplasty * Patient with arthroplasty for acute trauma * Patient on immunosuppressantsimmunosuppressive drugs * Patient with inflammatory rheumatism * Patient with progressive cancer pathology * Allergies or intolerances concerning the modalities of selected skin preparations (Povidone Iodine, hypersensitivity to benzoyl peroxide) * Dermatological pathologies in the area to be treated * Acne treatment in the area to be treated within four weeks before inclusion * Patient without possible help from a third party for the application of Cutacnyl® 5% in the intervention group if necessary * Major under guardianship * Patient under the protection of justice * Patient not covered by social security
Where it's running
-
CHU d'Angers
Angers, France Recruiting -
CHU de Brest
Brest, France Recruiting -
CHU de Limoges
Limoges, France Recruiting -
CHU de Nantes
Nantes, France Recruiting -
CHU de Rennes
Rennes, France Recruiting -
CHU de Tours
Tours, France Recruiting
Study contacts
- Principal investigator: Stéphane CORVEC — Nantes University Hospital
- Study coordinator: Stéphane CORVEC
- Email: stephane.corvec@chu-nantes.fr
- Phone: 0240083955
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Four-session focal shock wave therapy for vulvodynia in women
This study looks at whether four weekly sessions of low-intensity focal shock wave therapy help women with vulvodynia in real-life clinical practice.
-
Reproducibility of Digital Bite Mark Overlays in Adults
This study tests how consistently different people can create digital bite mark overlays from 3D dental scans in adults who need routine dental care.
-
Dental care for people living with HIV in Pays de la Loire
This study looks at whether people living with HIV in Pays de la Loire need any special dental management based on their health data.
-
68Ga-FAPI-46 PET imaging to stage ATTR-CM and spot progression
This study tests whether a gallium-68 labeled FAPI PET scan can help stage transthyretin cardiac amyloidosis and identify patients whose disease is progressing.
-
IL-1β blocker after pancreatic transplant to help prevent graft thrombosis
This trial tests whether adding Anakinra right after pancreatic transplant is safe for patients to see if it helps protect the new pancreas.
-
Synovial tissue biomarker study to guide PVNS management
Researchers will collect and analyze synovial tissue from adults with PVNS to see if tissue markers can help tailor treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.